Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2006
07/04/2006US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
07/04/2006US7070961 Amplifying preferential target nucleic acids; obtain biochip, couple nucleotide sequences to chip, incubate with sample containing target nucleotide sequences, expose to primer, amplify and recover nucleotids sequences
07/04/2006US7070960 Forming monoclonal antibodies; hybridomas culture; variations in concentration of solute; monitoring gene expression
07/04/2006US7070951 Dewaxing kit for immunostaining tissue specimens
07/04/2006US7070949 Protein mixture analysis by mass spectrometry
07/04/2006US7070948 Using enzymes; analysing by determination hydrogen peroxide
07/04/2006US7070946 Polypeptide for use in the diagnosis and treatment of bone disorders
07/04/2006US7070945 Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment
07/04/2006US7070944 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby
07/04/2006US7070943 Detection of protein conformations in single cells
07/04/2006US7070942 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5
07/04/2006US7070941 Methods and compositions for tagging via azido substrates
07/04/2006US7070940 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
07/04/2006US7070939 Methods for detecting vasculopathies and tumors
07/04/2006US7070938 Measuring activity of endothelial growth factor modulator; obtain modulator, incubate with kinase, isolate phosphorylated substrate, remove label, detecting adjustment in kinase activity
07/04/2006US7070937 Detection adjustment in end groups of albumin; circulating protein in human blood, binding to metals; quantitative analysis; antibodies; immunoassay
07/04/2006US7070936 Method for designing protein kinase inhibitors
07/04/2006US7070931 Controlling gene expression; calibration
07/04/2006US7070927 Methods and compositions for efficient nucleic acid sequencing
07/04/2006US7070924 Method of detecting cell death and detection reagent
07/04/2006US7070922 Surface treatment
07/04/2006US7070921 Monitoring enzymatic activity; incubate substrate and binding particles, incubate substrate and enzyme, detect and evaluate enzymatic response
07/04/2006US7070920 Screening arrangment for screening immunoassay tests and agglutination tests
07/04/2006US7070793 Antigen protein and nucleic acid coding for said protein
07/04/2006US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof
07/04/2006US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections
07/04/2006US7070790 peptides and recombinant envelope 1 and core proteins derived from specific gene sequences and their use in diagnostic methods and vaccines.
07/04/2006US7070789 Hybrid polypeptides as vaccine
07/04/2006US7070779 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
07/04/2006US7070776 inhibiting an immune response by reacting B7 positive cells with an antibody which binds with B7 antigen having a specific amino acid sequence
07/04/2006US7070760 injecting platelet derived proteins having a pI of 6.5-9.5 and detecting the occurrence of delayed type hypersensitivity (DTH) reaction at the injection site; positive reacting indicates high likelihood of being schizophrenic
07/04/2006US7070740 Method and apparatus for processing biomolecule arrays
07/04/2006US7070739 two dimensional centrifugation on the basis of sedimentation rate and isopycnic banding density through zones of immobilized reagents to which they are resistant, for detecting banded particles by light scatter or fluorescence using dyes; useful in clinical trials of new antibiotics and antivirals
07/04/2006US7070680 Biosensor
07/04/2006US7070564 Devices for physiological fluid sampling and methods of using the same
07/04/2006US7070110 Hand-wearable coded data reader
07/04/2006US7069769 Ultraviolet photoacoustic ozone detection
07/04/2006CA2531907A1 Arrangement and method for the analysis of the strength of a specimen of reducible material that contains iron
07/04/2006CA2531860A1 Method for the analysis of a test specimen of reducible material that contains iron
07/04/2006CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein
07/04/2006CA2372551C Improved structure and method for testing bond strength and/or removing integrated circuit devices bonded to substrates
07/04/2006CA2328940C Soil test
07/04/2006CA2264721C A1 adenosine receptor antagonists
07/04/2006CA2260870C Phytofluors as fluorescent labels
07/04/2006CA2223760C Method for determining alcohol consumption rates
07/04/2006CA2205359C Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-beta peptide (x->=41) and tau
07/04/2006CA2172689C Method and apparatus for determining the wax appearance temperature of paraffinic petroleum oils
07/04/2006CA2123069C Immunoassay for analytes in samples using alkylating agents
06/2006
06/30/2006CA2531863A1 Determining the position and angular orientation of food products
06/30/2006CA2531857A1 Portioning apparatus and method
06/30/2006CA2531621A1 Predetermining portioning yield
06/30/2006CA2531437A1 Detection of polynucleotides on nucleic acid arrays using azido-modified triphosphate nucleotide analogs
06/29/2006WO2006069403A2 Methods for producing soluble multi-membrane-spanning proteins
06/29/2006WO2006069373A2 Diagnosis of preeclampsia
06/29/2006WO2006069366A1 Methods of protein profiling by thiolation
06/29/2006WO2006069263A1 Use of sequence specific polymers in chemical detection
06/29/2006WO2006069188A1 Method for drug screening and characterization by ion flux analysis
06/29/2006WO2006069142A2 Methods for determining cellular response to stimuli
06/29/2006WO2006068975A2 Binding proteins specific for human matriptase
06/29/2006WO2006068935A1 Resuspension of magnetizable particles
06/29/2006WO2006068906A1 Sensor and methods for measuring select components in sheetmaking systems
06/29/2006WO2006068891A1 Method of separating unattached raman-active tag from bioassay or other reaction mixture
06/29/2006WO2006068822A1 Notch receptor agonists and uses
06/29/2006WO2006068758A2 Detection, prevention and treatment of breast cancer
06/29/2006WO2006068745A1 Methods for determining cellular response to stimuli
06/29/2006WO2006068646A1 Methods for the identification and the isolation of epitope specific antibodies
06/29/2006WO2006068640A1 Protein phosphorylation in egfr-signaling pathways
06/29/2006WO2006068619A1 Device and use thereof
06/29/2006WO2006068469A1 Methods for the functional determination of mannan-binding-lectin associated serine proteases (masps) and complexes thereof
06/29/2006WO2006068326A1 Novel polypeptide and the use thereof
06/29/2006WO2006068249A1 Method of obesity test and method of screening of preventive or therapeutic drug for obesity
06/29/2006WO2006068239A1 Method of examining inflammatory disease and method of screening remedy for inflammatory disease
06/29/2006WO2006068206A1 Reagent for assaying antigen and method of assaying antigen
06/29/2006WO2006068170A1 Method for improvement of heat stability of glucose dehydrogenase
06/29/2006WO2006068059A1 Method of quantitative determination for factor derived from pigment epithelium
06/29/2006WO2006067940A1 Lactic acid bacteria binding to human abo blood types
06/29/2006WO2006067611A1 Methods of modulating the activities of alpha7 nicotinic acetylcholine receptor
06/29/2006WO2006067572A2 A method for diagnosing and monitoring cellular reservoirs of disease
06/29/2006WO2006067565A2 Truncated gabab receptor and methods of use thereof
06/29/2006WO2006067517A1 Analytical composition and method
06/29/2006WO2006067504A2 Low volume assay apparatus and method
06/29/2006WO2006067427A2 Method of diagnosis
06/29/2006WO2006067402A2 Agents inibiting the cathelin-like protein cap18/ll-37
06/29/2006WO2006067317A2 Method for increasing the hydrophobicity of an external coating for an analysis device such as biochip, said device and method for the production thereof
06/29/2006WO2006067276A1 Utilization of nanowires in chemical and biological analysis
06/29/2006WO2006067063A2 Screening methods for identification of modulators of cytokine class i
06/29/2006WO2006066977A1 Novel use of fluorescence resonance energy transfer
06/29/2006WO2006066959A1 Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these
06/29/2006WO2006066918A2 Proton conductors
06/29/2006WO2006066917A2 Use of asc as a marker for colorectal cancer
06/29/2006WO2006066916A1 Use of microsomal dipeptidase as a marker for colorectal cancer
06/29/2006WO2006066915A1 Use of cyfra 21-1 as a marker for colorectal cancer
06/29/2006WO2006066912A2 Detection of a therapeutic antibody in an experimental animal
06/29/2006WO2006066804A1 In-vitro diagnostic system for analytes, comprising immunospecific detection
06/29/2006WO2006066649A2 Oil composition for lubricating an egr equipped diesel engine and an egr equipped diesel engine comprising same
06/29/2006WO2006066599A2 Mas related g protein coupled receptors as drug targets
06/29/2006WO2006066587A1 Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
06/29/2006WO2006066408A1 Cancer specific antibody and cell surface proteins
06/29/2006WO2006066368A1 Method for screening and selecting ligands
06/29/2006WO2006054326A3 Animal model for studying substances with cardiotherapeutic and anti-hypertensive activity